logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 8
  • 1
    Novak, Rodger, Dr
    Company Director born in June 1967
    Individual (6 offsprings)
    Officer
    2015-10-08 ~ 2022-06-27
    OF - Director → CIF 0
  • 2
    Kulkarni, Samarth, Dr
    Born in November 1978
    Individual (2 offsprings)
    Officer
    2022-06-27 ~ now
    OF - Director → CIF 0
  • 3
    Smith, Brendan
    Born in October 1975
    Individual (2 offsprings)
    Officer
    2021-12-17 ~ 2023-03-13
    OF - Director → CIF 0
  • 4
    Jones, Jonathan
    Company Director born in September 1973
    Individual (2 offsprings)
    Officer
    2015-10-08 ~ 2020-06-30
    OF - Director → CIF 0
  • 5
    Dylan-hyde, Tyler
    Company Director born in October 1961
    Individual (2 offsprings)
    Officer
    2015-10-08 ~ 2018-03-31
    OF - Director → CIF 0
  • 6
    Tomsicek, Michael
    Born in November 1965
    Individual (2 offsprings)
    Officer
    2020-06-30 ~ 2021-12-17
    OF - Director → CIF 0
  • 7
    Foy, Shaun Patrick
    Born in February 1970
    Individual (7 offsprings)
    Officer
    2014-02-07 ~ 2015-10-08
    OF - Director → CIF 0
  • 8
    14, Baarerstrasse, Ch-6300, Zug V8, Switzerland
    Corporate (3 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

CRISPR THERAPEUTICS LTD

Period: 2014-02-07 ~ now
Company number: 08882624
Registered name
CRISPR THERAPEUTICS LTD - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02024-01-01 ~ 2024-12-31
12023-01-01 ~ 2023-12-31
Turnover/Revenue
95,619 GBP2024-01-01 ~ 2024-12-31
1,821,439 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
95,616 GBP2024-01-01 ~ 2024-12-31
1,813,039 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
3 GBP2024-01-01 ~ 2024-12-31
8,400 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
22,977 GBP2024-01-01 ~ 2024-12-31
Profit/Loss on Ordinary Activities Before Tax
22,980 GBP2024-01-01 ~ 2024-12-31
8,400 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
22,980 GBP2024-01-01 ~ 2024-12-31
8,400 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
22,980 GBP2024-01-01 ~ 2024-12-31
8,400 GBP2023-01-01 ~ 2023-12-31
Debtors
33,442 GBP2024-12-31
476,817 GBP2023-12-31
Cash at bank and in hand
1,011,968 GBP2024-12-31
1,102,193 GBP2023-12-31
Current Assets
1,045,410 GBP2024-12-31
1,579,010 GBP2023-12-31
Creditors
Current
524,181 GBP2024-12-31
1,080,761 GBP2023-12-31
Net Current Assets/Liabilities
521,229 GBP2024-12-31
498,249 GBP2023-12-31
Total Assets Less Current Liabilities
521,229 GBP2024-12-31
498,249 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2022-12-31
Retained earnings (accumulated losses)
521,228 GBP2024-12-31
498,248 GBP2023-12-31
489,848 GBP2022-12-31
Equity
521,229 GBP2024-12-31
498,249 GBP2023-12-31
489,849 GBP2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
22,980 GBP2024-01-01 ~ 2024-12-31
8,400 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
5,152 GBP2024-01-01 ~ 2024-12-31
1,596 GBP2023-01-01 ~ 2023-12-31
Trade Debtors/Trade Receivables
Current
4,966 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
1,500 GBP2024-12-31
1,500 GBP2023-12-31
Other Debtors
Current
1 GBP2024-12-31
1 GBP2023-12-31
Amount of value-added tax that is recoverable
Current
20,116 GBP2024-12-31
74,588 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
33,442 GBP2024-12-31
476,817 GBP2023-12-31
Trade Creditors/Trade Payables
Current
5,231 GBP2024-12-31
181,415 GBP2023-12-31
Amounts owed to group undertakings
Current
501,962 GBP2024-12-31
866,653 GBP2023-12-31
Other Creditors
Current
4,988 GBP2024-12-31
4,988 GBP2023-12-31
Accrued Liabilities
Current
12,000 GBP2024-12-31
27,705 GBP2023-12-31

  • CRISPR THERAPEUTICS LTD
    Info
    Registered number 08882624
    The Old Bakehouse, Course Road, Ascot, Berkshire SL5 7HL
    PRIVATE LIMITED COMPANY incorporated on 2014-02-07 (12 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-07-01
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.